Selected research
Industry Research
Carrier RNA Industry Research Report 2026
Market perspective
The global Carrier RNA market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Carrier RNA is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Carrier RNA is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Carrier RNA is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Carrier RNA include Magen Biotechnology, Sigma-Aldrich, Top-Bio, Beyotime, Applygen, Thermo Fisher Scientific, SparkJade, Gegene Tech and Sangon Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Carrier RNA market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Carrier RNA Market by Company
Magen Biotechnology
Sigma-Aldrich
Top-Bio
Beyotime
Applygen
Thermo Fisher Scientific
SparkJade
Gegene Tech
Sangon Biotech
Solarbio
BIO SWAMP
Yeasen
Carrier RNA Segment by Type
Acryl Carrier
Glycogen Precipitation
Others
Carrier RNA Segment by Application
Hospital Clinical Laboratory
Biotechnology Company
Scientific Research Institutions
Third-Party Testing Organization
Others
Carrier RNA Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Carrier RNA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Carrier RNA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Carrier RNA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Carrier RNA manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Carrier RNA by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Carrier RNA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Acryl Carrier
- Glycogen Precipitation
- Others
Applications
- Hospital Clinical Laboratory
- Biotechnology Company
- Scientific Research Institutions
- Third-Party Testing Organization
- Others
Companies covered
- Magen Biotechnology
- Sigma-Aldrich
- Top-Bio
- Beyotime
- Applygen
- Thermo Fisher Scientific
- SparkJade
- Gegene Tech
- Sangon Biotech
- Solarbio
- BIO SWAMP
- Yeasen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Carrier RNA Market Size (2021-2032)
- 2.2.2 Global Carrier RNA Sales (2021-2032)
- 2.2.3 Global Carrier RNA Market Average Price (2021-2032)
- 2.3 Carrier RNA by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Acryl Carrier
- 2.3.3 Glycogen Precipitation
- 2.3.4 Others
- 2.4 Carrier RNA by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Clinical Laboratory
- 2.4.3 Biotechnology Company
- 2.4.4 Scientific Research Institutions
- 2.4.5 Third-Party Testing Organization
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Carrier RNA Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Carrier RNA Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Carrier RNA Revenue of Manufacturers (2021-2026)
- 3.4 Global Carrier RNA Average Price by Manufacturers (2021-2026)
- 3.5 Global Carrier RNA Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Carrier RNA, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Carrier RNA, Product Type & Application
- 3.8 Global Manufacturers of Carrier RNA, Established Date
- 3.9 Global Carrier RNA Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Magen Biotechnology
- 4.1.1 Magen Biotechnology Company Information
- 4.1.2 Magen Biotechnology Business Overview
- 4.1.3 Magen Biotechnology Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Magen Biotechnology Carrier RNA Product Portfolio
- 4.1.5 Magen Biotechnology Recent Developments
- 4.2 Sigma-Aldrich
- 4.2.1 Sigma-Aldrich Company Information
- 4.2.2 Sigma-Aldrich Business Overview
- 4.2.3 Sigma-Aldrich Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sigma-Aldrich Carrier RNA Product Portfolio
- 4.2.5 Sigma-Aldrich Recent Developments
- 4.3 Top-Bio
- 4.3.1 Top-Bio Company Information
- 4.3.2 Top-Bio Business Overview
- 4.3.3 Top-Bio Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Top-Bio Carrier RNA Product Portfolio
- 4.3.5 Top-Bio Recent Developments
- 4.4 Beyotime
- 4.4.1 Beyotime Company Information
- 4.4.2 Beyotime Business Overview
- 4.4.3 Beyotime Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Beyotime Carrier RNA Product Portfolio
- 4.4.5 Beyotime Recent Developments
- 4.5 Applygen
- 4.5.1 Applygen Company Information
- 4.5.2 Applygen Business Overview
- 4.5.3 Applygen Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Applygen Carrier RNA Product Portfolio
- 4.5.5 Applygen Recent Developments
- 4.6 Thermo Fisher Scientific
- 4.6.1 Thermo Fisher Scientific Company Information
- 4.6.2 Thermo Fisher Scientific Business Overview
- 4.6.3 Thermo Fisher Scientific Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Thermo Fisher Scientific Carrier RNA Product Portfolio
- 4.6.5 Thermo Fisher Scientific Recent Developments
- 4.7 SparkJade
- 4.7.1 SparkJade Company Information
- 4.7.2 SparkJade Business Overview
- 4.7.3 SparkJade Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 SparkJade Carrier RNA Product Portfolio
- 4.7.5 SparkJade Recent Developments
- 4.8 Gegene Tech
- 4.8.1 Gegene Tech Company Information
- 4.8.2 Gegene Tech Business Overview
- 4.8.3 Gegene Tech Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gegene Tech Carrier RNA Product Portfolio
- 4.8.5 Gegene Tech Recent Developments
- 4.9 Sangon Biotech
- 4.9.1 Sangon Biotech Company Information
- 4.9.2 Sangon Biotech Business Overview
- 4.9.3 Sangon Biotech Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sangon Biotech Carrier RNA Product Portfolio
- 4.9.5 Sangon Biotech Recent Developments
- 4.10 Solarbio
- 4.10.1 Solarbio Company Information
- 4.10.2 Solarbio Business Overview
- 4.10.3 Solarbio Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Solarbio Carrier RNA Product Portfolio
- 4.10.5 Solarbio Recent Developments
- 4.11 BIO SWAMP
- 4.11.1 BIO SWAMP Company Information
- 4.11.2 BIO SWAMP Business Overview
- 4.11.3 BIO SWAMP Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 BIO SWAMP Carrier RNA Product Portfolio
- 4.11.5 BIO SWAMP Recent Developments
- 4.12 Yeasen
- 4.12.1 Yeasen Company Information
- 4.12.2 Yeasen Business Overview
- 4.12.3 Yeasen Carrier RNA Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Yeasen Carrier RNA Product Portfolio
- 4.12.5 Yeasen Recent Developments
5 Global Carrier RNA Market Scenario by Region
- 5.1 Global Carrier RNA Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Carrier RNA Sales by Region: 2021-2032
- 5.2.1 Global Carrier RNA Sales by Region: 2021-2026
- 5.2.2 Global Carrier RNA Sales by Region: 2027-2032
- 5.3 Global Carrier RNA Revenue by Region: 2021-2032
- 5.3.1 Global Carrier RNA Revenue by Region: 2021-2026
- 5.3.2 Global Carrier RNA Revenue by Region: 2027-2032
- 5.4 North America Carrier RNA Market Facts & Figures by Country
- 5.4.1 North America Carrier RNA Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Carrier RNA Sales by Country (2021-2032)
- 5.4.3 North America Carrier RNA Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Carrier RNA Market Facts & Figures by Country
- 5.5.1 Europe Carrier RNA Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Carrier RNA Sales by Country (2021-2032)
- 5.5.3 Europe Carrier RNA Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Carrier RNA Market Facts & Figures by Country
- 5.6.1 Asia Pacific Carrier RNA Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Carrier RNA Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Carrier RNA Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Carrier RNA Market Facts & Figures by Country
- 5.7.1 South America Carrier RNA Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Carrier RNA Sales by Country (2021-2032)
- 5.7.3 South America Carrier RNA Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Carrier RNA Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Carrier RNA Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Carrier RNA Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Carrier RNA Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Carrier RNA Sales by Type (2021-2032)
- 6.1.1 Global Carrier RNA Sales by Type (2021-2032) & (L)
- 6.1.2 Global Carrier RNA Sales Market Share by Type (2021-2032)
- 6.2 Global Carrier RNA Revenue by Type (2021-2032)
- 6.2.1 Global Carrier RNA Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Carrier RNA Revenue Market Share by Type (2021-2032)
- 6.3 Global Carrier RNA Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Carrier RNA Sales by Application (2021-2032)
- 7.1.1 Global Carrier RNA Sales by Application (2021-2032) & (L)
- 7.1.2 Global Carrier RNA Sales Market Share by Application (2021-2032)
- 7.2 Global Carrier RNA Revenue by Application (2021-2032)
- 7.2.1 Global Carrier RNA Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Carrier RNA Revenue Market Share by Application (2021-2032)
- 7.3 Global Carrier RNA Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Carrier RNA Value Chain Analysis
- 8.1.1 Carrier RNA Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Carrier RNA Production Mode & Process
- 8.2 Carrier RNA Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Carrier RNA Distributors
- 8.2.3 Carrier RNA Customers
9 Global Carrier RNA Analyzing Market Dynamics
- 9.1 Carrier RNA Industry Trends
- 9.2 Carrier RNA Industry Drivers
- 9.3 Carrier RNA Industry Opportunities and Challenges
- 9.4 Carrier RNA Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst